Scully M, Cataland SR, Peyvandi F, et al. Results of the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Hercules Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura. ASH 59th Annual Meeting & Exhibition, abstract LBA-1.
ZUMA-5: hoog responspercentage axicabtagene ciloleucel bij gerecidiveerd/refractair indolent NHL
jan 2022 | Lymfoom